Sarepta Therapeutics reported $545.57M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
Avrobio Inc AVRO:US $ 17.13M 2.26M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Capricor Therapeutics CAPR:US $ 14.32M 10.19M
Daiichi Sankyo 4568:JP Y 406816M 11548M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Esperion Therapeutics ESPR:US $ 82.28M 3.19M
Gilead Sciences GILD:US $ 9220M 662M
Insmed INSM:US $ 113.82M 11.43M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
IONIS PHARMACEUT IONS:US $ 228.45M 12.1M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Moderna Inc MRNA:US 6.81B 2.43B
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Newlink Genetics NLNK:US $ 5.24M 0.11M
Novavax NVAX:US $ 2261M 129.31M
Ptc Therapeutics PTCT:US $ 567.37M 90.6M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Sangamo Biosciences SGMO:US $ 119.99M 1.46M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
YTE INCY:US $ 926.67M 40.51M